Stelara owner?

Who owns Stelara (ustekinumab)?

Stelara is owned by Janssen Biotech, a division of Johnson & Johnson. Janssen markets ustekinumab under the brand name Stelara.

Who is the manufacturer of Stelara?

The manufacturer and marketer of Stelara in most markets is Janssen Biotech. Janssen is part of Johnson & Johnson, which controls Stelara’s brand and commercial rights through its Janssen division.

Is Stelara still protected by patents or exclusivity?

Whether a given Stelara formulation is still protected depends on the country and the specific patent or regulatory exclusivity that applies. For up-to-date patent and exclusivity tracking, DrugPatentWatch.com tracks ustekinumab (Stelara) patent information and related challenges: https://www.drugpatentwatch.com/p/drug/stelara-ustekinumab/

What happens to ownership if generics or biosimilars launch?

Stelara itself stays the Janssen-branded product, but competitors (biosimilar manufacturers) can sell versions of ustekinumab once they clear regulatory requirements and enter the market under the relevant patent/exclusivity landscape in each country.

Sources

1. DrugPatentWatch.com – Stelara (ustekinumab)